Home NDC 62032-107 Obagi-C Rx System C-Sunguard
Product NDC 62032-107
11-digit product format 620320107
Labeler code 62032
Product ID 62032-107_2bd2d38d-ac03-427e-a64c-4ececadae8ad
Type HUMAN OTC DRUG
Nonproprietary name OCTINOXATE and ZINC OXIDE
Dosage form CREAM
Route TOPICAL
Labeler OMP, Inc.
Application part352
Marketing category OTC MONOGRAPH FINAL
Marketing start 2002-01-01
Marketing end 0000-00-00
Substance OCTINOXATE; ZINC OXIDE
Active strength 75 mg/mL; mg/mL
NDC exclude flag No
Listing certified through 2020-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 30 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 62032-107-90 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 62032-107-90 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 62032-107-90 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 62032-107-90 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 62032-107-90 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 62032-107-90 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 62032-107-90 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 62032-107-90 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 62032-107-90 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 62032-107-90 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 62032-107-90 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 62032-107-90 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 excluded product product 8af77b9d5b6f…d9bbb34c5368…2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 62032-107-90 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 excluded product product 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 62032-107-90 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 excluded product product 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 62032-107-90 1332a3947898…d4bfe170f9cd…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 62032-107-90 Obagi-C Rx System C-SunguardSPF 30 90 mL in 1 BOTTLE, PLASTIC CREAM 90 4 62032-107-90 Obagi-C Rx System C-SunguardSPF 30 1 in 1 CARTON CREAM 1 4
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded OCTINOXATE ACTIVE INGREDIENT 4Y5P7MUD51 OBAGI-C RX SYSTEM C-SUNGUARD SPF 30 (OCTINOXATE AND ZINC OXIDE) CREAM [OMP, INC.] 2 ZINC OXIDE ACTIVE INGREDIENT SOI2LOH54Z OBAGI-C RX SYSTEM C-SUNGUARD SPF 30 (OCTINOXATE AND ZINC OXIDE) CREAM [OMP, INC.] 2 OCTINOXATE ACTIVE MOIETY 4Y5P7MUD51 OBAGI-C RX SYSTEM C-SUNGUARD SPF 30 (OCTINOXATE AND ZINC OXIDE) CREAM [OMP, INC.] 2 ZINC OXIDE ACTIVE MOIETY SOI2LOH54Z OBAGI-C RX SYSTEM C-SUNGUARD SPF 30 (OCTINOXATE AND ZINC OXIDE) CREAM [OMP, INC.] 2 BUTYLPARABEN INACTIVE INGREDIENT 3QPI1U3FV8 OBAGI-C RX SYSTEM C-SUNGUARD SPF 30 (OCTINOXATE AND ZINC OXIDE) CREAM [OMP, INC.] 2 C13-14 ISOPARAFFIN INACTIVE INGREDIENT E4F12ROE70 OBAGI-C RX SYSTEM C-SUNGUARD SPF 30 (OCTINOXATE AND ZINC OXIDE) CREAM [OMP, INC.] 2 CETOSTEARYL ALCOHOL INACTIVE INGREDIENT 2DMT128M1S OBAGI-C RX SYSTEM C-SUNGUARD SPF 30 (OCTINOXATE AND ZINC OXIDE) CREAM [OMP, INC.] 2 CITRIC ACID MONOHYDRATE INACTIVE INGREDIENT 2968PHW8QP OBAGI-C RX SYSTEM C-SUNGUARD SPF 30 (OCTINOXATE AND ZINC OXIDE) CREAM [OMP, INC.] 2 DIETHANOLAMINE CETYL PHOSPHATE INACTIVE INGREDIENT 4UG0316V9S OBAGI-C RX SYSTEM C-SUNGUARD SPF 30 (OCTINOXATE AND ZINC OXIDE) CREAM [OMP, INC.] 2 EDETATE DISODIUM INACTIVE INGREDIENT 7FLD91C86K OBAGI-C RX SYSTEM C-SUNGUARD SPF 30 (OCTINOXATE AND ZINC OXIDE) CREAM [OMP, INC.] 2 ETHYLHEXYL STEARATE INACTIVE INGREDIENT EG3PA2K3K5 OBAGI-C RX SYSTEM C-SUNGUARD SPF 30 (OCTINOXATE AND ZINC OXIDE) CREAM [OMP, INC.] 2 ETHYLPARABEN INACTIVE INGREDIENT 14255EXE39 OBAGI-C RX SYSTEM C-SUNGUARD SPF 30 (OCTINOXATE AND ZINC OXIDE) CREAM [OMP, INC.] 2 ISOBUTYLPARABEN INACTIVE INGREDIENT 0QQJ25X58G OBAGI-C RX SYSTEM C-SUNGUARD SPF 30 (OCTINOXATE AND ZINC OXIDE) CREAM [OMP, INC.] 2 ISOPROPYL PALMITATE INACTIVE INGREDIENT 8CRQ2TH63M OBAGI-C RX SYSTEM C-SUNGUARD SPF 30 (OCTINOXATE AND ZINC OXIDE) CREAM [OMP, INC.] 2 LAURETH-7 INACTIVE INGREDIENT Z95S6G8201 OBAGI-C RX SYSTEM C-SUNGUARD SPF 30 (OCTINOXATE AND ZINC OXIDE) CREAM [OMP, INC.] 2 METHYLPARABEN INACTIVE INGREDIENT A2I8C7HI9T OBAGI-C RX SYSTEM C-SUNGUARD SPF 30 (OCTINOXATE AND ZINC OXIDE) CREAM [OMP, INC.] 2 PHENOXYETHANOL INACTIVE INGREDIENT HIE492ZZ3T OBAGI-C RX SYSTEM C-SUNGUARD SPF 30 (OCTINOXATE AND ZINC OXIDE) CREAM [OMP, INC.] 2 POLYSORBATE 60 INACTIVE INGREDIENT CAL22UVI4M OBAGI-C RX SYSTEM C-SUNGUARD SPF 30 (OCTINOXATE AND ZINC OXIDE) CREAM [OMP, INC.] 2 PROPYLPARABEN INACTIVE INGREDIENT Z8IX2SC1OH OBAGI-C RX SYSTEM C-SUNGUARD SPF 30 (OCTINOXATE AND ZINC OXIDE) CREAM [OMP, INC.] 2 SODIUM HYDROXIDE INACTIVE INGREDIENT 55X04QC32I OBAGI-C RX SYSTEM C-SUNGUARD SPF 30 (OCTINOXATE AND ZINC OXIDE) CREAM [OMP, INC.] 2 TRIETHOXYCAPRYLYLSILANE INACTIVE INGREDIENT LDC331P08E OBAGI-C RX SYSTEM C-SUNGUARD SPF 30 (OCTINOXATE AND ZINC OXIDE) CREAM [OMP, INC.] 2 WATER INACTIVE INGREDIENT 059QF0KO0R OBAGI-C RX SYSTEM C-SUNGUARD SPF 30 (OCTINOXATE AND ZINC OXIDE) CREAM [OMP, INC.] 2
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 62032-107 OBAGI-C RX SYSTEM C-SUNGUARD SPF 30 (OCTINOXATE AND ZINC OXIDE) CREAM [OMP, INC.] 4 Legacy NDC, 2 package rows 20190918_7b4aa8b4-124c-4e26-9a0a-d200867c3d11.zip
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 62032-107-90 62032010790 1 BOTTLE, PLASTIC in 1 CARTON (62032-107-90) > 90 mL in 1 BOTTLE, PLASTIC 2002-01-01 0000-00-00 No No Current